| Ad Title: |
A Rapid Onset and Short Duration Insulin Secretagogue, Mitiglinide, In Combination With Metformin versus Metformin Along in Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Placebo-Ctonrolled Trial for 6 Months. |
| Study Title: |
A Rapid Onset and Short Duration Insulin Secretagogue, Mitiglinide, In Combination With Metformin versus Metformin Along in Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Placebo-Ctonrolled Trial for 6 Months. |
| Protocol Number: |
082007-016 |
| Department(s) involved in the Study: |
Int Med - Endocrinology
|
| Purpose of the Study: |
People who have Type 2 diabetes mellitus have higher levels of glucose (sugar) in their blood. Metformin is usually prescribed to lower the levels of glucose in the blood. However, after a meal, the levels of glucose in the blood can get high again. When the body keeps going from low to high, then high to low levels of glucose in the blood, patients have a difficult time keeping the glucose levels in a safe range. Mitiglinide is taken before a meal to help the body quickly release insulin into the blood, which helps to keep the glucose levels from getting too high after the meal. |
| Participant Eligibility: |
If you're taking metformin alone, it may not be enough. You may be eligible to help doctors evaluate a new, investigational medication for type 2 diabetes that may help your metformin.
To be eligible for this study, you must:
- Be an adult 18 to 75 years of age
- Have a medical diagnosis of type 2 diabetes at least 6 months prior to enrollment
- Have taken metformin for at least 4 months and at a stable dose for at least 12 weeks without experiencing any significant abdominal discomfort
Qualified participants will receive study-related medical evaluations and investigational medication at no cost.
|
| Disease/Condition Under Study: |
Diabetes |
| Cancer Related Study: |
No
|
| Study Drug(s): |
Metformin Hydrochloride (Glucophage), Mitiglinide
|
| Study Device(s): |
|
| Study Doctor: |
Dr. Philip Raskin |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
Other: See Comments
|
Yes
|
|
| Contact Phone: |
214_648_4716 |
| Email: |
philip.raskin@utsouthwestern.edu |
| Other Information: |
|
| Website Keywords: |
Diabetes, Endocrinology, Wellness
|
| Medical Keywords: |
Blood sugar, Hyperglycemia
|
